NORTHERN IRELAND
and Randox, as well as global investors, Northern Ireland is on an upward trajectory. The investments from leading medical and life science companies such as Terumo, Stryker, and TEVA Pharmaceutical Industries further underscore the region’s potential to continue growing and advancing in the industry.
Government commitment The government’s unwavering commitment is to support the growth of Northern Ireland’s life and health sciences sector. As part of a substantial £1.3bn government investment package, over £150m will be invested in Northern Ireland through City and Growth Deals to advance health technology, clinical trials, data analytics, and medical devices. This investment aims to support international innovation hubs and facilitate collaborations between businesses within and outside Northern Ireland. The goal is to take advantage of the region’s educational institutions’ expertise and develop state-of-the-art technologies, products, and services. The Health Innovation Research Alliance Northern Ireland (HIRANI) also provides strategic direction and unified sector representation, showcasing Northern Ireland’s expertise and the government’s secure and confident commitment to the sector’s future.
Unlocking global success The healthcare sector is consistently identified as a
Axial3D
key priority sector for the GCC countries. Northern Ireland’s life and health sciences sector priorities align well with the GCC’s transformation vision. Invest Northern Ireland has been actively present in the GCC for 30 years, facilitating bilateral trade, investment, academic and research links between the two regions. This includes organising trade missions, providing market intelligence, and supporting business partnerships. Recently, we hosted an inward visit from key sector representatives across India, the Middle East, and Africa region, showcasing Northern Ireland’s capabilities in the Life & Health Sciences. At Arab Health 2025, as part of the UK pavilion,
Northern Ireland is proudly showcasing 7 companies that offer innovative solutions to the world’s healthcare challenges, such as: n Eakin Respiratory a company based in Northern Ireland, exemplifies how Northern Irish businesses are elevating the life and health sciences sector across the GCC. Specialising in the production of respiratory care products, its innovative designs have positively impacted an estimated 7.5 million patients worldwide for anaesthesia and the resuscitation and respiratory support of 65,000 babies and 35,000 adults.
Queen’s University Belfast 10 UKHEALTHCARE P A VILION. COM
n BioPanda, an ISO13485 certified company in Northern Ireland specialises in the design, development, manufacture and supply of in vitro test kits for clinical laboratories, drugs of abuse testing, veterinary practice, and food safety, both locally and globally. With an active and growing
DUB AI 2025
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52
